$4M sweet spot round size
Most of their 536 investments are in rounds between $23M and $75M
1989
ReCode Therapeutics raised $50M on September 19, 2023
Investors: Sanofi Ventures, Solasta Ventures, Vida Ventures, LLC, Leaps by Bayer, Osage University Partners (OUP), MPM Capital and OrbiMed Advisors
Star Therapeutics raised $90M on September 5, 2023
Investors: Qatar Investment Authority, Westlake Village BioPartners®, Sofinnova Ventures, Russia technology fund, Redmile Group, Soleus Capital Management, L.P., New Leaf Venture Partners, NYBC Ventures, RA Capital Management, L.P. and OrbiMed Advisors
Fore Biotherapeutics raised $75M on August 23, 2023
Investors: Medicxi, S.R. One Ltd, 3B Future Health Fund, Wellington Management, HBM Partners AG and OrbiMed Advisors
Valneva raised $50M on August 17, 2023
Investors: OrbiMed Advisors
Vicore Pharma AB raised $46M on June 9, 2023
Investors: Suvretta Capital Management LLC, SEB, AP3 - Third Swedish National Pension Fund, HealthCap, Swedbank Robur and OrbiMed Advisors
Undisclosed raised $200M on June 8, 2023
Investors: TCG X, Omega Funds, Samsara BioCapital, Enavate Sciences, Decheng Capital, Wellington Management and OrbiMed Advisors
InspireMD raised $114M on May 15, 2023
Investors: Velan Capital, LifeSci Capital, LLC, Soleus Capital Management, L.P., Marshall Wace and OrbiMed Advisors
Magenta Medical Ltd. raised $55M on May 3, 2023
Investors: ALIVE Israel HealthTech Fund, Pitango Venture Capital and OrbiMed Advisors
Convergent Therapeutics, Inc. raised $90M on May 3, 2023
Investors: The Invus Group, RA Capital Management, L.P. and OrbiMed Advisors
Aer Therapeutics, Inc. raised $36M on April 13, 2023
Investors: Canaan and OrbiMed Advisors